This company develops automated, chip-based infrastructure to generate scalable and reliable biological datasets for training and testing predictive models. Their Bio-Server replaces manual wet-lab workflows with miniaturized, high-throughput experiments to overcome data quantity and consistency limitations in biological research. This approach accelerates discovery by providing model-ready data essential for advancing AI-driven drug discovery and computational biology.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional biochemical research often faces limitations in throughput, precision, and scalability due to reliance on manual processes and conventional laboratory equipment. Access to advanced microfluidics technology, which can enhance these aspects, remains limited for many research labs.
Solution
Diatom Bio provides a cloud-based digital microfluidics ecosystem designed to enhance and accelerate biochemical research. The platform leverages microelectromechanical systems (MEMS) to enable researchers to conduct experiments with greater precision and efficiency. By democratizing access to digital microfluidics technology, Diatom Bio empowers research labs to streamline workflows, increase throughput, and achieve more reliable results. The ecosystem facilitates a range of biochemical applications, fostering innovation and discovery.
Target Audience
The primary target audience includes research labs and researchers in the biochemical field seeking to improve their experimental workflows and gain access to advanced microfluidics technology.
Features
- Cloud-based platform for remote experiment design, execution, and analysis
- Digital microfluidics technology based on microelectromechanical systems (MEMS)
- Support for a variety of biochemical applications